PHK
DYN icon

Point72 Hong Kong’s Dyne Therapeutics DYN Stock Holding History

Point72 Hong Kong’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$199K Buy
+15,713
New +$179K 0.01% 313
2022
Q3 		– Sell
-132
Closed -$1K – 2035
2022
Q2 		$1K Sell
132
-454
-77% -$3.13K ﹤0.01% 1810
2022
Q1 		$6K Buy
+586
New +$4.99K ﹤0.01% 1655
2021
Q4 		– Sell
-2,308
Closed -$37K – 2010
2021
Q3 		$37K Buy
+2,308
New +$40.9K ﹤0.01% 1594

Other funds holding DYN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Hong Kong's DYN Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Dyne Therapeutics (DYN) in Q3 2025: 15,713 shares worth $199K. The stake represents 0.01% of the portfolio and ranks #313 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in DYN as recently as Q2 2022.

Point72 Hong Kong first reported a position in DYN in Q3 2021 and has held it in 4 quarters since. 207 funds tracked by Wall St. Rank hold DYN as of Q3 2025.

  • Point72 Hong Kong held 15,713 shares of Dyne Therapeutics worth $199K as of Q3 2025.
  • Dyne Therapeutics was a new Point72 Hong Kong position in Q3 2025.
  • Dyne Therapeutics made up 0.01% of Point72 Hong Kong's portfolio in Q3 2025, its #313 holding.
  • Point72 Hong Kong first reported a position in Dyne Therapeutics in Q3 2021 and has held it in 4 quarters since.
  • 207 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.